Virology Market Size & Share | Global Analysis Report by 2028
The virology market is projected to reach US$ 5,276.48 million by 2028 from US$ 4,108.27 million in 2021; it is expected to register a CAGR of 3.6% from 2021 to 2028.
Virology is among the significant sections of the healthcare system. It has an extensive application in the vaccine development, diagnostics, treatment therapies, and others. The virology market players are constantly involved in product innovations and developments to sustain the competition in the market. They explore various scopes for product innovations. For instance, for COVID-19, market players are investing significantly in the development of vaccines, testing kits, and other related products and services. Below are a few of the market developments related to the virology market.- In August 2021, the U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine known as the Pfizer-BioNTech COVID-19 Vaccine. It will be marketed as ComiRNAty (Koe-mir’-na-tee). The vaccine is intended to prevent COVID-19 disease in individuals aged 16 years and above. It is also available under emergency use authorization (EUA).
- In April 2021, CerTest Biotec launched its CE-marked COVID-19 diagnostic test for the BD MAX System.
- In May 2020, Bio-Rad received FDA approval for emergency use authorization for the COVID-19 total antibody test.
- In May 2020, Aalto Bio Reagents launched New Recombinant Eukaryotic SARS-CoV-2 S1-S2 Spike Proteins.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Virology Market: Strategic Insights
Market Size Value in US$ 4,108.27 million in 2021 Market Size Value by US$ 5,276.48 million by 2028 Growth rate CAGR of 3.6% from 2021 - 2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Virology Market: Strategic Insights
| Market Size Value in | US$ 4,108.27 million in 2021 |
| Market Size Value by | US$ 5,276.48 million by 2028 |
| Growth rate | CAGR of 3.6% from 2021 - 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market InsightsGrowing Adoption of Minimally Invasive and Non-Invasive Esthetic Procedures Drive Virology Market Growth
Viruses such as human immunodeficiency virus (HIV), flu virus, zika virus, Ebola virus, SARS-CoV-2, and poliovirus infect large population across the world. As the virus mutate and evolve continuously, drug resistance becomes a major challenge in viral infection management among the humans and animals. A virus transmits through various media based on its type. For instance, some viruses cause respiratory viral diseases, such as flu, common cold, and respiratory syncytial virus infection, and they are transmitted via droplets generated through coughing or sneezing, whereas some gastrointestinal viral diseases are transmitted through direct contact with the feces of infected people or through contaminated food or water. As per the UNAIDS Global HIV & AIDS statistics, more than 37.7 million people across the world were infected by HIV in 2020.The International Committee on Taxonomy of Viruses (ICTV) declared the novel coronavirus that caused COVID-19 as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in February 2020. The virus has undergone mutation a couple of times since its outbreak, which has added to the severity of the COVID-19 pandemic. For instance, as per the COVID-19 tracker data by the Centers for Disease Control and Prevention (CDC), as of August 2021, the seven-day case rate per 100,000 is 299.4, and over 164,952 new cases are reported in the US. Moreover, as per the European Centre for Disease Prevention and Control, as of August 2021, the total count of COVID-19 cases reached ~36,307,572 patients in the European Economic Area (EEA). Thus, such rising prevalence of viral infections is driving the growth of the virology market.
Virology Market Report Scope
Type-Based Insights
Based on type, the virology market is further segmented into diagnostic tests, viral infection controlling techniques, antiviral therapeutics, and interferons. In 2021, the diagnostic test segment is expected to hold the largest share of the market, and viral infection controlling techniques segment is estimated to register the highest CAGR during 2021–2028.Application-Based Insights
Based on application, the market is segmented into skin and soft tissue infections, respiratory tract infections, GI tract infections, sexually transmitted diseases, urinary tract infection, and others. In 2021, the respiratory tract infections segment is estimated to hold the largest share of the market, and it is expected to register the highest CAGR during 2021–2028.Companies operating in the virology market emphasize on adopting the product innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.
Virology Market – Segmentation
By Type
- Diagnostic Test
- DNA Virus Testing
- RNA Virus Testing
- Others
- Viral Infection Controlling Techniques
- Active Prophylaxis
- Passive Prophylaxis
- Antiviral Therapeutics
- Virucidal Agents
- Antiviral Agents
- Immunomodulators
- Interferons
By Application
- Skin and Soft Tissue Infections
- Respiratory Tract Infections
- GI Tract Infections
- Sexually Transmitted Diseases
- Urinary Tract Infections
- Others
By End User
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical and Biotechnological Companies
- Research and Academic Institutes
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
- South and Central America
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Abbott
- Johnson & Johnson Services, Inc.
- F. Hoffmann-LA Roche Ltd.
- Thermo Fisher Scientific, Inc.
- Qiagen
- Illumina, Inc.
- Siemens AG
- GlaxoSmithKline Plc
- Gilead Sciences, Inc.
- AbbVie, Inc.pyright names given on respective websites.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The global virology market based on based on type is segmented into diagnostic test, viral infection controlling techniques, antiviral therapeutics, and interferons. In 2021, Antiviral Therapeutics segment is estimated to account for the largest market share in the global virology market. the growth can be attributed to increasing prevalence of human immunodeficiency virus (HIV) and increasing research and development investment by private and public companies for antiviral drugs.
The factors that are driving and restraining factors that will affect virology market in the coming years. Factors such as rising prevalence of viral infectious diseases and increasing product launches, are driving the market growth. However, availability of alternative products and high cost of production of products are likely to hamper the growth of the market.
The virology market majorly consists of the players such as Abbott, Johnson & Johnson Services, Inc., F. Hoffmann-LA Roche Ltd., Thermo Fisher Scientific, Inc., Qiagen, Illumina, Inc., Siemens AG, GlaxoSmithKline Plc, Gilead Sciences, Inc., and AbbVie, Inc. are amongst others.
The global virology market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America dominates the global virology market due to factors such as technological advancement, increasing product launches, and increasing investment in healthcare and research. The transmission of infectious diseases globally has made diagnosis mandatory for travelers. Today, the diseases are spreading faster around the world, which is further bolstering the demand for diagnostic tools as they can help control the outbreak at an early stage. For instance, in September 2019, the FDA approved OraQuick Ebola Rapid Antigen Test, a new rapid diagnostic test for Ebola in the US.
Asia Pacific is expected to be the fastest growing region Asia Pacific is expected to expand at a high growth rate due to large patient population, increasing government support to provide better healthcare services, and increasing product launches by market players. For instance, in 2018, Cepheid initiated the HBDC Access Program1 for the diagnosis of HIV, viral hepatitis (HCV), and human papillomavirus (HPV)2 at a relatively lower price. The company is aiming to make tests that would be more accessible to lower-income countries.
Virology is a detailed study of viruses that focuses on the structure, classification, evolution, and genetics of viruses. The virology market caters to the prevention and development of treatments for several viral diseases. The increasing prevalence of emerging infectious diseases (EIDs)—chikungunya, Ebola, West Nile virus, severe acute respiratory syndrome (SARS), and Lyme disease is driving the growth of the virology market. The key driving factors for the market growth are, rising prevalence of viral infections and other infectious diseases along with growing awareness about diagnosis and treatment of the disease.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Virology Market – By Type
1.3.2 Global Virology Market – By Application
1.3.3 Global Virology Market – By End User
1.3.4 Global Virology Market– By Geography
2. Global Virology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Virology Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. Virology Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Viral Infectious Diseases
5.1.2 Increasing Product Launches
5.2 Market Restraints
5.2.1 Availability of Alternative Products and High Cost of Production of Products
5.3 Market Opportunities
5.3.1 Tremendous Growth Potential in Developing Economies
5.4 Future Trends
5.4.1 Continuous Demand for Cost-Effective Products
5.5 Impact Analysis
6. Virology Market– Global Analysis
6.1 Global Virology Market Revenue Forecast and Analysis
6.2 Global Virology Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Virology Market Analysis – By Type
7.1 Overview
7.2 Virology Market Revenue Share, by Type (2021 and 2028)
7.3 Diagnostic Test
7.3.1 Overview
7.3.2 Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Deoxyribonucleic Acid (DNA) Virus Testing
7.3.2.1.1 Overview
7.3.2.1.2 DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Ribonucleic Acid (RNA) Virus Testing
7.3.2.2.1 Overview
7.3.2.2.2 RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Others
7.3.2.3.1 Overview
7.3.2.3.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Viral Infection Controlling Techniques
7.4.1 Overview
7.4.2 Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Active Prophylaxis
7.4.2.1.1 Overview
7.4.2.1.2 Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Passive Prophylaxis
7.4.2.2.1 Overview
7.4.2.2.2 Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Antiviral Therapeutics
7.5.1 Overview
7.5.2 Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1 Virucidal Agents
7.5.2.1.1 Overview
7.5.2.1.2 Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Antiviral Agents
7.5.2.2.1 Overview
7.5.2.2.2 Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Immunomodulators
7.5.2.3.1 Overview
7.5.2.3.2 Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Interferons
7.6.1 Overview
7.6.2 Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8. Virology Market Analysis – By Application
8.1 Overview
8.2 Virology Market, by Application 2021 & 2028 (%)
8.3 Skin and Soft Tissue Infections
8.3.1 Overview
8.3.2 Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Respiratory Tract Infections
8.4.1 Overview
8.4.2 Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.5 GI Tract Infections
8.5.1 Overview
8.5.2 GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Sexually Transmitted Diseases
8.6.1 Overview
8.6.2 Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Urinary Tract Infections
8.7.1 Overview
8.7.2 Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9. Virology Market Analysis – By End-User
9.1 Overview
9.2 Virology Market Revenue Share, by End User (2021 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pharmaceutical and Biotechnological Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Research and Academic Institutes
9.6.1 Overview
9.6.2 Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)
10. Global Virology Market – Geographic Analysis
10.1 North America: Virology Market
10.1.1 Overview
10.1.2 North America: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.3 North America: Virology Market, by Type, 2019–2028 (USD Million)
10.1.3.1 North America: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.3.2 North America: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.3.3 North America: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.4 North America: Virology Market, by Application, 2019–2028 (USD Million)
10.1.5 North America: Virology Market, by End User, 2019–2028 (USD Million)
10.1.6 North America: Virology Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Virology Market– Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3 US: Virology Market, by Type, 2019–2028 (USD Million)
10.1.6.1.3.1 US: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.6.1.3.2 US: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.6.1.3.3 US: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.6.1.4 US: Virology Market, by Application, 2019–2028 (USD Million)
10.1.6.1.5 US: Virology Market, by End User, 2019–2028 (USD Million)
10.1.6.2 Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3 Canada: Virology Market, by Type, 2019–2028 (USD Million)
10.1.6.2.3.1 Canada: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.6.2.3.2 Canada: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.6.2.3.3 Canada: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.6.2.4 Canada: Virology Market, by Application, 2019–2028 (USD Million)
10.1.6.2.5 Canada: Virology Market, by End User, 2019–2028 (USD Million)
10.1.6.3 Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3 Mexico: Virology Market, by Type, 2019–2028 (USD Million)
10.1.6.3.3.1 Mexico: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.6.3.3.2 Mexico: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.6.3.3.3 Mexico: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.6.3.4 Mexico: Virology Market, by Application, 2019–2028 (USD Million)
10.1.6.3.5 Mexico: Virology Market, by End User, 2019–2028 (USD Million)
10.2 Europe: Virology Market Revenue and Forecasts to 2028
10.2.1 Europe: Virology Market Revenue and Forecasts to 2028 (US$ million)
10.2.2 Europe Virology Market Revenue and Forecasts to 2028, By Type (US$ million)
10.2.2.1 Europe: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.2.2.2 Europe: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.2.2.3 Europe: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.2.3 Europe Virology Market Revenue and Forecasts to 2028, by Application (US$ million)
10.2.4 Europe Virology Market Revenue and Forecasts to 2028, by End User (US$ million)
10.2.5 Europe Virology Market Revenue and Forecasts to 2028, By Country (%)
10.2.5.1 UK Virology Market Revenue and Forecasts to 2028 (US$ million)
10.2.5.1.1 UK Virology Market Revenue and Forecasts to 2028 (US$ million)
10.2.5.1.2 UK Virology Market Revenue and Forecasts to 2028, By Type (US$ million)
10.2.5.1.2.1 UK: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.2.5.1.2.2 UK: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.2.5.1.2.3 UK: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.2.5.1.3 UK Virology Market Revenue and Forecasts to 2028, by Application (US$ million)
10.2.5.1.4 UK Virology Market Revenue and Forecasts to 2028, by End User (US$ million)
10.2.5.2 Germany Virology Market Revenue and Forecasts to 2028 (US$ million)
10.2.5.2.1 Germany Virology Market Revenue and Forecasts to 2028 (US$ million)
10.2.5.2.2 Germany Virology Market Revenue and Forecasts to 2028, By Type (US$ million)
10.2.5.2.2.1 Germany: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.2.5.2.2.2 Germany: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.2.5.2.2.3 Germany: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.2.5.2.3 Germany Virology Market Revenue and Forecasts to 2028, by Application (US$ million)
10.2.5.2.4 Germany Virology Market Revenue and Forecasts to 2028, by End User (US$ million)
10.2.5.3 France Virology Market Revenue and Forecasts to 2028 (US$ million)
10.2.5.3.1 France Virology Market Revenue and Forecasts to 2028 (US$ million)
10.2.5.3.2 France Virology Market Revenue and Forecasts to 2028, By Type (US$ million)
10.2.5.3.2.1 France: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.2.5.3.2.2 France: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.2.5.3.2.3 France: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.2.5.3.3 France Virology Market Revenue and Forecasts to 2028, by Application (US$ million)
10.2.5.3.4 France Virology Market Revenue and Forecasts to 2028, by End User (US$ million)
10.2.5.4 Italy Virology Market Revenue and Forecasts to 2028 (US$ million)
10.2.5.4.1 Italy Virology Market Revenue and Forecasts to 2028 (US$ million)
10.2.5.4.2 Italy Virology Market Revenue and Forecasts to 2028, By Type (US$ million)
10.2.5.4.2.1 Italy: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.2.5.4.2.2 Italy: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.2.5.4.2.3 Italy: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.2.5.4.3 Italy Virology Market Revenue and Forecasts to 2028, by Application (US$ million)
10.2.5.4.4 Italy Virology Market Revenue and Forecasts to 2028, by End User (US$ million)
10.2.5.5 Spain Virology Market Revenue and Forecasts to 2028 (US$ million)
10.2.5.5.1 Spain Virology Market Revenue and Forecasts to 2028 (US$ million)
10.2.5.5.2 Spain Virology Market Revenue and Forecasts to 2028, By Type (US$ million)
10.2.5.5.2.1 Spain: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.2.5.5.2.2 Spain: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.2.5.5.2.3 Spain: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.2.5.5.3 Spain Virology Market Revenue and Forecasts to 2028, by Application (US$ million)
10.2.5.5.4 Spain Virology Market Revenue and Forecasts to 2028, by End User (US$ million)
10.2.5.6 Rest of Europe Virology Market Revenue and Forecasts to 2028 (US$ million)
10.2.5.6.1 Rest of Europe Virology Market Revenue and Forecasts to 2028 (US$ million)
10.2.5.6.2 Rest of Europe Virology Market Revenue and Forecasts to 2028, By Type (US$ million)
10.2.5.6.2.1 Rest of Europe: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.2.5.6.2.2 Rest of Europe: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.2.5.6.2.3 Rest of Europe: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.2.5.6.3 Rest of Europe Virology Market Revenue and Forecasts to 2028, by Application (US$ million)
10.2.5.6.4 Rest of Europe Virology Market Revenue and Forecasts to 2028, by End User (US$ million)
10.3 Asia Pacific: Virology Market
10.3.1 Overview
10.3.2 Asia Pacific: Virology Market - Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Virology Market, By Type, 2019–2028 (USD Million)
10.3.3.1 Asia Pacific: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.3.3.2 Asia Pacific: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.3.3.3 Asia Pacific: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.3.4 Asia Pacific: Virology Market, by Application, 2019–2028 (USD Million)
10.3.5 Asia Pacific: Virology Market, by End User, 2019–2028 (USD Million)
10.3.6 Asia Pacific: Virology Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.1 China: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.2 China: Virology Market, By Type, 2019–2028 (USD Million)
10.3.6.1.2.1 China: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.3.6.1.2.2 China: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.3.6.1.2.3 China: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.3.6.1.3 China: Virology Market, by Application, 2019–2028 (USD Million)
10.3.6.1.4 China: Virology Market, by End User, 2019–2028 (USD Million)
10.3.6.2 Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.1 Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.2 Japan: Virology Market, By Type, 2019–2028 (USD Million)
10.3.6.2.2.1 Japan: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.3.6.2.2.2 Japan: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.3.6.2.2.3 Japan: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.3.6.2.3 Japan: Virology Market, by Application, 2019–2028 (USD Million)
10.3.6.2.4 Japan: Virology Market, by End User, 2019–2028 (USD Million)
10.3.6.3 India: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.1 India: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.2 India: Virology Market, By Type, 2019–2028 (USD Million)
10.3.6.3.2.1 India: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.3.6.3.2.2 India: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.3.6.3.2.3 India: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.3.6.3.3 India: Virology Market, by Application, 2019–2028 (USD Million)
10.3.6.3.4 India: Virology Market, by End User, 2019–2028 (USD Million)
10.3.6.4 South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.1 South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.2 South Korea: Virology Market, By Type, 2019–2028 (USD Million)
10.3.6.4.2.1 South Korea: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.3.6.4.2.2 South Korea: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.3.6.4.2.3 South Korea: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.3.6.4.3 South Korea: Virology Market, by Application, 2019–2028 (USD Million)
10.3.6.4.4 South Korea: Virology Market, by End User, 2019–2028 (USD Million)
10.3.6.5 Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.1 Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.2 Australia: Virology Market, By Type, 2019–2028 (USD Million)
10.3.6.5.2.1 Australia: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.3.6.5.2.2 Australia: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.3.6.5.2.3 Australia: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.3.6.5.3 Australia: Virology Market, by Application, 2019–2028 (USD Million)
10.3.6.5.4 Australia: Virology Market, by End User, 2019–2028 (USD Million)
10.3.6.6 Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.2 Rest of Asia Pacific: Virology Market, By Type, 2019–2028 (USD Million)
10.3.6.6.2.1 Rest of Asia Pacific: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.3.6.6.2.2 Rest of Asia Pacific: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.3.6.6.2.3 Rest of Asia Pacific: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.3.6.6.3 Rest of Asia Pacific: Virology Market, by Application, 2019–2028 (USD Million)
10.3.6.6.4 Rest of Asia Pacific: Virology Market, by End User, 2019–2028 (USD Million)
10.4 Middle East & Africa: Virology Market Revenue and Forecast to 2028
10.4.1 Overview
10.4.2 Middle East & Africa: Virology Market - Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
10.4.3.1 Middle East & Africa: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.4.3.2 Middle East & Africa: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.4.3.3 Middle East & Africa: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.4.4 Middle East & Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.4.5 Middle East & Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4.6 Middle East & Africa: Virology Market, by Country, 2021 & 2028 (%)
10.4.6.1 Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.1 Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.2 Saudi Arabia Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.2.1 Saudi Arabia: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.4.6.1.2.2 Saudi Arabia: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.4.6.1.2.3 Saudi Arabia: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.4.6.1.3 Saudi Arabia: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.4 Saudi Arabia: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4.6.2 UAE: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.1 UAE: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.2 UAE Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.2.1 UAE: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.4.6.2.2.2 UAE: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.4.6.2.2.3 UAE: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.4.6.2.3 UAE: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.4 UAE: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4.6.3 South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.1 South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.2 South Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.2.1 South Africa: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.4.6.3.2.2 South Africa: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.4.6.3.2.3 South Africa: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.4.6.3.3 South Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.4 South Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4.6.4 Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.4.1 Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.4.2 Rest of Middle East and Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
10.4.6.4.2.1 Rest of Middle East and Africa: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.4.6.4.2.2 Rest of Middle East and Africa: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.4.6.4.2.3 Rest of Middle East and Africa: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.4.6.4.3 Rest of Middle East and Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.4.6.4.4 Rest of Middle East and Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.5 South and Central America: Virology Market
10.5.1 Overview
10.5.2 South and Central America: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.5.3 South and Central America: Virology Market, By Type, 2019–2028 (USD Million)
10.5.3.1 South and Central America: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.5.3.2 South and Central America: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.5.3.3 South and Central America: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.5.4 South and Central America: Virology Market, by Application, 2019–2028 (USD Million)
10.5.5 South and Central America: Virology Market, by End User, 2019–2028 (USD Million)
10.5.6 South and Central America: Virology Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.1 Brazil: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.2 Brazil: Virology Market, By Type, 2019–2028 (USD Million)
10.5.6.1.2.1 Brazil: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.5.6.1.2.2 Brazil: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.5.6.1.2.3 Brazil: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.5.6.1.3 Brazil: Virology Market, by Application, 2019–2028 (USD Million)
10.5.6.1.4 Brazil: Virology Market, by End User, 2019–2028 (USD Million)
10.5.6.2 Argentina: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.1 Argentina: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.2 Argentina: Virology Market, By Type, 2019–2028 (USD Million)
10.5.6.2.2.1 Argentina: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.5.6.2.2.2 Argentina: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.5.6.2.2.3 Argentina: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.5.6.2.3 Argentina: Virology Market, by Application, 2019–2028 (USD Million)
10.5.6.2.4 Argentina: Virology Market, by End User, 2019–2028 (USD Million)
10.5.6.3 Rest of South and Central America: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.1 Rest of South and Central America: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.2 Rest of South and Central America: Virology Market, By Type, 2019–2028 (USD Million)
10.5.6.3.2.1 Rest of South and Central America: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.5.6.3.2.2 Rest of South and Central America: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.5.6.3.2.3 Rest of South and Central America: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.5.6.3.3 Rest of South and Central America: Virology Market, by Application, 2019–2028 (USD Million)
10.5.6.3.4 Rest of South and Central America: Virology Market, by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Global Virology Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Virology Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Abbott
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Johnson and Johnson Services, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. HOFFMANN-LA ROCHE LTD.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 THERMO FISHER SCIENTIFIC INC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 QIAGEN
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Illumina, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Siemens AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 GlaxoSmithKline Plc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 AbbVie Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Gilead Sciences, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 3. North America Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 4. North America Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 5. North America Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. North America Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. US: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. US: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)
Table 9. US: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)
Table 10. US: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)
Table 11. US: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. US Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Canada: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Canada: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)
Table 15. Canada: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)
Table 16. Canada: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)
Table 17. Canada: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 18. Canada: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)
Table 21. Mexico: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)
Table 22. Mexico: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)
Table 23. Mexico: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 24. Mexico: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 25. Europe Virology Market Revenue and Forecasts to 2028, By Type (US$ million).
Table 26. Europe Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 27. Europe Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 28. Europe Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)
Table 29. Europe Virology Market Revenue and Forecasts to 2028, by Application (US$ million)
Table 30. Europe Virology Market Revenue and Forecasts to 2028, by End User (US$ million)
Table 31. UK Virology Market Revenue and Forecasts to 2028, By Type US$ million)
Table 32. UK Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 33. UK Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 34. UK Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 35. UK Virology Market Revenue and Forecasts to 2028, by Application US$ million)
Table 36. UK Virology Market Revenue and Forecasts to 2028, by End User US$ million)
Table 37. Germany Virology Market Revenue and Forecasts to 2028, By Type (US$ million)
Table 38. Germany Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 39. Germany Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 40. Germany Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 41. Germany Virology Market Revenue and Forecasts to 2028, by Application US$ million)
Table 42. Germany Virology Market Revenue and Forecasts to 2028, by End User US$ million)
Table 43. France Virology Market Revenue and Forecasts to 2028, By Type (US$ million)
Table 44. France Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 45. France Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 46. France Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 47. France Virology Market Revenue and Forecasts to 2028, by Application (US$ million)
Table 48. France Virology Market Revenue and Forecasts to 2028, by End User (US$ million)
Table 49. Italy Virology Market Revenue and Forecasts to 2028, By Type (US$ million)
Table 50. Italy Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 51. Italy Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 52. Italy Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 53. Italy Virology Market Revenue and Forecasts to 2028, by Application (US$ million)
Table 54. Italy Virology Market Revenue and Forecasts to 2028, by End User (US$ million)
Table 55. Spain Virology Market Revenue and Forecasts to 2028, By Type (US$ million)
Table 56. Spain Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 57. North America Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 58. Spain Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 59. Spain Virology Market, by Application – Revenue and Forecast to 2028 by Application (USD Million)
Table 60. Spain Virology Market, by End User – Revenue and Forecast to 2028 by End User (USD Million)
Table 61. Rest of Europe Virology Market Revenue and Forecasts to 2028, By Type (US$ million)
Table 62. Rest of Europe Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 63. Rest of Europe Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 64. Rest of Europe Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 65. Rest of Europe Virology Market Revenue and Forecasts to 2028, by Application (US$ million)
Table 66. Rest of Europe Virology Market Revenue and Forecasts to 2028, by End User (US$ million)
Table 67. Asia Pacific: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 68. Asia Pacific Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 69. Asia Pacific Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 70. Asia Pacific Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 71. Asia Pacific Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 72. Asia Pacific Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 73. China: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 74. China Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 75. China Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 76. China Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 77. China: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 78. China: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 79. Japan: Virology Market, By Type– Revenue and Forecast to 2028 (USD Million)
Table 80. Japan Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 81. Japan Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 82. Japan Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 83. Japan: Virology Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 84. Japan: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 85. India: Virology Market, By Type– Revenue and Forecast to 2028 (USD Million)
Table 86. India Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 87. India Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 88. India Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 89. India: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 90. India: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 91. South Korea: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 92. South Korea Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 93. South Korea Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 94. South Korea Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 95. South Korea: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 96. South Korea: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 97. Australia: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 98. Australia Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 99. Australia Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 100. Australia Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 101. Australia: Virology Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 102. Australia: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 103. Rest of Asia Pacific: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 104. Rest of Asia Pacific Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 105. Rest of Asia Pacific Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 106. Rest of Asia Pacific Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 107. Rest of Asia Pacific: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 108. Rest of Asia Pacific: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 109. Middle East & Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 110. Middle East & Africa Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 111. Middle East & Africa Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 112. Middle East & Africa Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 113. Middle East & Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 114. Middle East & Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 115. Saudi Arabia Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 116. Saudi Arabia Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 117. Saudi Arabia Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 118. Saudi Arabia Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 119. Saudi Arabia: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 120. Saudi Arabia: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 121. UAE Virology Market, By Type – Revenue and Forecast to 2028(USD Million)
Table 122. UAE Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 123. UAE Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 124. UAE Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 125. UAE: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 126. UAE: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 127. South Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 128. South Africa Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 129. South Africa Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 130. South Africa Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 131. South Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 132. South Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of Middle East and Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of Middle East and Africa Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of Middle East and Africa Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 136. Rest of Middle East and Africa Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 137. Rest of Middle East and Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 138. Rest of Middle East and Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 139. South and Central America: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 140. South and Central America Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 141. South and Central America Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 142. South and Central America Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 143. South and Central America: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 144. South and Central America: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 145. Brazil: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 146. Brazil Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 147. Brazil Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 148. Brazil Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 149. Brazil: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 150. Brazil: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 151. Argentina: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 152. Argentina Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 153. Argentina Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 154. Argentina Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 155. Argentina: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 156. Argentina: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 157. Rest of South and Central America: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 158. Rest of South and Central America Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 159. Rest of South and Central America Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 160. Rest of South and Central America Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 161. Rest of South and Central America: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 162. Rest of South and Central America: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 163. Organic Developments Done by Companies
Table 164. Inorganic Developments Done by Companies
Table 165. Glossary of Terms, Virology Market
LIST OF FIGURES
Figure 1. Virology Market Segmentation
Figure 2. Virology Segmentation, By Region
Figure 3. Global Virology Market Overview
Figure 4. Antiviral Therapeutics Held the Largest Share of the Type Segment in Virology Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Virology Market, by Geography (US$ Million)
Figure 7. Global Virology Market– Leading Country Markets (US$ Million)
Figure 8. Global Virology Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe and PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Global Virology Market: Impact Analysis of Drivers and Restraints
Figure 15. Global Virology Market– Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Virology Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Market Positioning of Key Players in Global Virology Market
Figure 18. Virology Market Revenue Share, by Type (2021 and 2028)
Figure 19. Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Antiviral Therapeutics : Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Virology Market, by Application 2021 & 2028 (%)
Figure 32. Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Virology Market Revenue Share, by End User (2021 and 2028)
Figure 39. Hospitals & Clinics: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. North America: Virology Market, by Key Country – Revenue (2021) (USD Million)
Figure 44. North America Virology Market Revenue and Forecast to 2028 (USD Million)
Figure 45. North America: Virology Market, by Country, 2021 & 2028 (%)
Figure 46. US: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Europe: Virology Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 50. Europe Virology Market Revenue and Forecasts to 2028 (US$ million)
Figure 51. Europe Virology Market Revenue and Forecasts to 2028, By Country (%)
Figure 52. UK Virology Market Revenue and Forecasts to 2028 (US$ million)
Figure 53. Germany Virology Products Market Revenue and Forecasts to 2028 (US$ million)
Figure 54. France Virology Market Revenue and Forecasts to 2028 (US$ million)
Figure 55. Italy Virology Market Revenue and Forecasts to 2028 (US$ million)
Figure 56. Spain Virology Market Revenue and Forecasts to 2028 (US$ million)
Figure 57. Rest of Europe Virology Market Revenue and Forecasts to 2028 (US$ million)
Figure 58. Asia Pacific: Virology Market, by Key Country – Revenue (2021) (USD Million)
Figure 59. Asia Pacific Virology Market Revenue and Forecast to 2028 (USD Million)
Figure 60. Asia Pacific: Virology Market, by Country, 2021 & 2028 (%)
Figure 61. China: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. India: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 64. South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. Middle East and Africa: Virology Market, by Key Country – Revenue (2021) (USD Million)
Figure 68. Middle East & Africa Virology Market Revenue and Forecast to 2028 (USD Million)
Figure 69. Middle East & Africa: Virology Treatment Market, by Country, 2021 & 2028 (%)
Figure 70. Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 71. UAE: Virology Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 72. South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 73. Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 74. South and Central America: Virology Market, by Key Country – Revenue (2021) (USD Million)
Figure 75. South and Central America Virology Market Revenue and Forecast to 2028 (USD Million)
Figure 76. South and Central America: Virology Market, by Country, 2021 & 2028 (%)
Figure 77. Brazil: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 78. Argentina: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 79. Rest of South and Central America: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 80. Impact of COVID-19 Pandemic in North American Country Markets
Figure 81. Impact of COVID-19 Pandemic on Virology Market in European Countries
Figure 82. Impact of COVID-19 Pandemic on Virology Market in Asia Pacific Countries
Figure 83. Impact of COVID-19 Pandemic on Virology Market in Middle East and African Countries
Figure 84. Impact of COVID-19 Pandemic on Virology Market in South and Central American Countries
Figure 85. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Virology Market
- Abbott
- Johnson And Johnson Services, Inc.
- F. HOFFMANN-LA ROCHE LTD.
- THERMO FISHER SCIENTIFIC INC.
- QIAGEN
- Illumina, Inc.
- Siemens AG
- Glaxosmithkline Plc
- Abbvie Inc.
- Gilead Sciences, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For